Skip to main content
. 2024 Apr 20;38(6):1236–1245. doi: 10.1038/s41375-024-02222-w

Fig. 5. 8CA/8AA and VEN synergistically inhibit the progression of R/R AML in vivo.

Fig. 5

A NSG mice were engrafted with 0.8 M R/R AML blasts, and after 5 days, they were treated with vehicle (n = 8), 12.5 mg/kg/day 8CA/5 mg/kg/day 8AA (n = 8), 20 mg/kg/day VEN (n = 7), or 8CA/8AA + VEN (n = 10) for 7 weeks. B The survival of mice receiving different treatments was monitored. *p ≤ 0.05, ***p ≤ 0.001.